The tumor cells mostly displayed a TGF-β intensity of 0 to 1+, whereas the intensity was increased to 1 to 2+ in the tumor stromal compartment in samples across the stages of disease progression (Figure 2A). This evidence concerns the gene TGFB1 and neoplasm.